Ignite Creation Date:
2024-05-06 @ 7:01 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05863364
Status:
RECRUITING
Last Update Posted:
2023-08-08
First Post:
2022-12-28
Brief Title:
Rifaximin for Preventing Progression and Complications in Patients With Decompensated Liver Cirrhosis
Sponsor:
Xin Zeng
Organization:
Shanghai East Hospital
Organization Data
Organization:
Shanghai East Hospital
Class:
OTHER
Study ID:
DFYY2022096
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xin Zeng
Lead Sponsor Class:
OTHER
Responsible Party:
Xin Zeng
Responsible Party Title:
Director of the department of gastroenterology
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Shanghai East Hospital
Old Name:
None
Old Organization:
None